Neurometrix, INC Form 4 insider transactions

Director David Goodman reports the vesting and conversion of restricted stock units into common stock of NeuroMetrix, Inc. on April 30, 2024.

Director Nancy Katz reports the vesting of restricted stock units into 5,396 shares of NeuroMetrix common stock on April 30, 2024.

Joshua Horowitz, a director at NeuroMetrix, Inc., filed an amendment to his Form 4 to report an inadvertent sale of 1,000 shares of common stock at $4.58 per share on April 22, 2024.

Director Joshua Horowitz reports acquisition of NeuroMetrix common stock and a grant of restricted stock units (RSUs).

Thomas Higgins, CFO of NeuroMetrix, Inc., reports the vesting of restricted stock units and subsequent tax withholding.

NeuroMetrix CEO Shai Gozani reports the vesting of restricted stock units and subsequent stock transactions.

Thomas Higgins, CFO of NeuroMetrix, Inc., reports the vesting of restricted stock units and subsequent transactions.

NeuroMetrix's CEO, Shai Gozani, reports the vesting of restricted stock units and subsequent transactions involving common stock.

Thomas T. Higgins, CFO of NeuroMetrix, Inc., reports the vesting of restricted stock units and subsequent stock transactions.

Shai Gozani, President & CEO of NeuroMetrix, Inc., reports transactions involving common stock and restricted stock units, including vesting and tax withholding, as per a pre-arranged plan.

Thomas Higgins, CFO of NeuroMetrix, Inc., reports the acquisition of 5,625 restricted stock units on November 22, 2023, vesting quarterly over three years starting January 1, 2024.

NeuroMetrix CEO Shai Gozani was granted 7,500 restricted stock units on November 22, 2023, following a 1-for-8 reverse stock split.

Thomas Higgins, CFO of NeuroMetrix, Inc., reports the vesting of restricted stock units and subsequent tax withholding.

NeuroMetrix CEO Shai Gozani reports the vesting of restricted stock units and subsequent tax withholding.